Patents Assigned to Young Pharmaceuticals Inc.
  • Publication number: 20130096203
    Abstract: An active agent delivery composition is provided that allows topical delivery of active agents including vitamin A and its derivatives. A polyhalogenic vehicle such as methoxyonafluorobutane or ethoxyonafluorobutane serves as a coupler for an active agent and a silicone carrier so as to allow solubilization of active agents not normally miscible in silicones and providing a moisture maintaining composition.
    Type: Application
    Filed: November 26, 2012
    Publication date: April 18, 2013
    Applicant: YOUNG PHARMACEUTICALS, INC.
    Inventor: YOUNG PHARMACEUTICALS, INC.
  • Patent number: 8337870
    Abstract: An active agent delivery composition is provided that allows topical delivery of active agents including vitamin A and its derivatives. A polyhalogenic vehicle such as methoxyonafluorobutane or ethoxyonafluorobutane serves as a coupler for an active agent and a silicone carrier so as to allow solubilization of active agents not normally miscible in silicones and providing a moisture maintaining composition.
    Type: Grant
    Filed: February 24, 2010
    Date of Patent: December 25, 2012
    Assignee: Young Pharmaceuticals, Inc.
    Inventor: John E. Kulesza
  • Patent number: 5248494
    Abstract: A lenitive composition is provided for application to the skin of an anthralin patient for reducing anthralin-induced inflammation and the staining associated with anthralin use. The lenitive composition is a single phase aqueous treating solution comprising an organic amine and a film-forming agent dissolved within a nontoxic dermatologically acceptable carrier. The organic amine is selected from the group consisting of lower alkyl and lower alkanol primary, secondary and tertiary amines and comprises about 1 to 25 percent by weight of the single phase aqueous treating solution. The solution is topically applied to the anthralin-treated areas so as to completely cover the treated areas. The solution is applied before or after anthralin wash off, preferably in the form of a fine spray or mist.
    Type: Grant
    Filed: June 10, 1992
    Date of Patent: September 28, 1993
    Assignee: Young Pharmaceuticals Inc.
    Inventors: John E. Kuleza, Lawrence Clifford M., Sam Shuster